Journal of Gastric Cancer

  • 제23권4호
  • /
  • Pages.535-548
  • /
  • 2023
  • /
  • 2093-582X(pISSN)
  • /
  • 2093-5641(eISSN)
대한위암학회 (The Korean Gastric Cancer Association)
권호 표지
DOI QR코드

DOI QR Code

Real-World Compliance of Surgical Treatment According to the Korean Gastric Cancer Guideline 2018: Evaluation From the Nationwide Survey Data 2019 in Korea

  • 투고 : 2023.04.01
  • 심사 : 2023.08.17
  • 발행 : 2023.10.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: This study evaluated real-world compliance with surgical treatment according to Korea's gastric cancer treatment guidelines. Materials and Methods: The 2018 Korean Gastric Cancer Treatment Guidelines were evaluated using the 2019 national survey data for surgically treated gastric cancer based on postoperative pathological results in Korea. In addition, the changes in surgical treatments in 2019 were compared with those in the 2014 national survey data implemented before the publication of the guidelines in 2018. The compliance rate was evaluated according to the algorithm recommended in the 2018 Korean guidelines. Results: The overall compliance rates in 2019 were 83% for gastric resection extent, 87% for lymph node dissection, 100% for surgical approach, and 83% for adjuvant chemotherapy, similar to 2014. Among patients with pathologic stages IB, II, and III disease who underwent total gastrectomy, the incidence of splenectomy was 8.08%, a practice not recommended by the guidelines. The survey findings revealed that 48.66% of the patients who underwent gastrectomy had pathological stage IV disease, which was not recommended by the 2019 guidelines. Compared to that in 2014, the rate of gastrectomy in stage IV patients was 54.53% in 2014. Compliance rates were similar across all regions of Korea, except for gastrectomy in patients with stage IV disease. Conclusions: Real-world compliance with gastric cancer treatment guidelines was relatively high in Korea.

키워드

과제정보

This research was supported by a nationwide survey project of the information committee funded by the Korean Gastric Cancer Association (grant number: KGCA2022IC9).

참고문헌

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424. https://doi.org/10.3322/caac.21492
  2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209-249. https://doi.org/10.3322/caac.21660
  3. Park SH, Kang MJ, Yun EH, Jung KW. Epidemiology of gastric cancer in Korea: trends in incidence and survival based on Korea central cancer registry data (1999-2019). J Gastric Cancer 2022;22:160-168. https://doi.org/10.5230/jgc.2022.22.e21
  4. Eom SS, Choi W, Eom BW, Park SH, Kim SJ, Kim YI, et al. A comprehensive and comparative review of global gastric cancer treatment guidelines. J Gastric Cancer 2022;22:3-23. https://doi.org/10.5230/jgc.2022.22.e10
  5. Worhunsky DJ, Ma Y, Zak Y, Poultsides GA, Norton JA, Rhoads KF, et al. Compliance with gastric cancer guidelines is associated with improved outcomes. J Natl Compr Canc Netw 2015;13:319-325. https://doi.org/10.6004/jnccn.2015.0044
  6. Ho VK, Damhuis RA, Hartgrink HH. Adherence to national guidelines for gastric cancer in the Netherlands: a retrospective population-based audit. Int J Cancer 2013;132:1156-1161. https://doi.org/10.1002/ijc.27718
  7. Zhao B, Blair SL, Katz MH, Lowy AM, Kelly KJ. Adherence with operative standards in the treatment of gastric cancer in the United States. Gastric Cancer 2020;23:550-560. https://doi.org/10.1007/s10120-019-01028-5
  8. Bristow RE, Chang J, Ziogas A, Anton-Culver H. Adherence to treatment guidelines for ovarian cancer as a measure of quality care. Obstet Gynecol 2013;121:1226-1234. https://doi.org/10.1097/AOG.0b013e3182922a17
  9. Jaap K, Fluck M, Hunsinger M, Wild J, Arora T, Shabahang M, et al. Analyzing the impact of compliance with national guidelines for pancreatic cancer care using the National Cancer Database. J Gastrointest Surg 2018;22:1358-1364. https://doi.org/10.1007/s11605-018-3742-9
  10. Kaslow SR, Ma Z, Hani L, Prendergast K, Vitiello G, Lee AY, et al. Adherence to guidelines at the patient-and hospital-levels is associated with improved overall survival in patients with gastric cancer. J Surg Oncol 2022;126:479-489. https://doi.org/10.1002/jso.26895
  11. Kaslow SR, Hani L, Sacks GD, Lee AY, Berman RS, Correa-Gallego C. Regional patterns of hospital-level guideline adherence in gastric cancer: an analysis of the national cancer database. Ann Surg Oncol 2023;30:300-308.
  12. Guideline Committee of the Korean Gastric Cancer Association (KGCA), Development Working Group & Review Panel. Korean practice guideline for gastric cancer 2018: an evidence-based, multi-disciplinary approach. J Gastric Cancer 2019;19:1-48. https://doi.org/10.5230/jgc.2019.19.e8
  13. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer 2021;24:1-21. https://doi.org/10.1007/s10120-020-01042-y
  14. Wang FH, Zhang XT, Li YF, Tang L, Qu XJ, Ying JE, et al. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun (Lond) 2021;41:747-795. https://doi.org/10.1002/cac2.12193
  15. Information Committee of the Korean Gastric Cancer Association. Korean Gastric Cancer Association-led nationwide survey on surgically treated gastric cancers in 2019. J Gastric Cancer 2021;21:221-235. https://doi.org/10.5230/jgc.2021.21.e27
  16. Information Committee of Korean Gastric Cancer Association. Korean Gastric Cancer Association nationwide survey on gastric cancer in 2014. J Gastric Cancer 2016;16:131-140. https://doi.org/10.5230/jgc.2016.16.3.131
  17. Lee K, Suh M, Jun JK, Choi KS. Impact of the COVID-19 pandemic on gastric cancer screening in South Korea: results from the Korean National Cancer Screening Survey (2017-2021). J Gastric Cancer 2022;22:264-272. https://doi.org/10.5230/jgc.2022.22.e35
  18. Okabe H, Tsunoda S, Tanaka E, Hisamori S, Kawada H, Sakai Y. Is laparoscopic total gastrectomy a safe operation? A review of various anastomotic techniques and their outcomes. Surg Today 2015;45:549-558. https://doi.org/10.1007/s00595-014-0901-9
  19. Eom SS, Park SH, Eom BW, Yoon HM, Kim YW, Ryu KW. Short and long-term surgical outcomes of laparoscopic total gastrectomy compared with open total gastrectomy in gastric cancer patients. Cancers (Basel) 2022;15:76.
  20. Kim TH, Kim IH, Kang SJ, Choi M, Kim BH, Eom BW, et al. Korean practice guidelines for gastric cancer 2022: an evidence-based, multidisciplinary approach. J Gastric Cancer 2023;23:3-106. https://doi.org/10.5230/jgc.2023.23.e11
  21. Wang FH, Zhang XT, Li YF, Tang L, Qu XJ, Ying JE, et al. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun (Lond) 2021;41:747-795. https://doi.org/10.1002/cac2.12193
  22. Kim HS, Kim JH, Kim JW, Kim BC. Chemotherapy in elderly patients with gastric cancer. J Cancer 2016;7:88-94. https://doi.org/10.7150/jca.13248
  23. Shih YH, Lin HC, Hsu CY. Adjuvant chemotherapy for older patients with stage II/III gastric cancer: a retrospective cohort study. J Clin Oncol 2023;41:303.
  24. Kasumova GG, Eskander MF, de Geus SW, Neto MM, Tabatabaie O, Ng SC, et al. Regional variation in the treatment of pancreatic adenocarcinoma: decreasing disparities with multimodality therapy. Surgery 2017;162:275-284.
  25. Kantor O, Wang CH, Yao K. Regional variation in performance for commission on cancer breast quality measures and impact on overall survival. Ann Surg Oncol 2018;25:3069-3075. https://doi.org/10.1245/s10434-018-6592-5
  26. Farrow NE, An SJ, Speicher PJ, Harpole DH Jr, D'Amico TA, Klapper JA, et al. Disparities in guideline-concordant treatment for node-positive, non-small cell lung cancer following surgery. J Thorac Cardiovasc Surg 2020;160:261-271.e1. https://doi.org/10.1016/j.jtcvs.2019.10.102
  27. Monson JR, Probst CP, Wexner SD, Remzi FH, Fleshman JW, Garcia-Aguilar J, et al. Failure of evidence-based cancer care in the United States: the association between rectal cancer treatment, cancer center volume, and geography. Ann Surg 2014;260:625-631. https://doi.org/10.1097/SLA.0000000000000928
  28. Thiels CA, Hanson KT, Habermann EB, Boughey JC, Grotz TE. Integrated cancer networks improve compliance with national guidelines and outcomes for resectable gastric cancer. Cancer 2020;126:1283-1294. https://doi.org/10.1002/cncr.32660
  29. Morgan E, Arnold M, Camargo MC, Gini A, Kunzmann AT, Matsuda T, et al. The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: a population-based modelling study. EClinicalMedicine 2022;47:101404.
  30. Jun JK, Choi KS, Lee HY, Suh M, Park B, Song SH, et al. Effectiveness of the Korean National Cancer Screening Program in reducing gastric cancer mortality. Gastroenterology 2017;152:1319-1328.e7. https://doi.org/10.1053/j.gastro.2017.01.029